Renowned Nollywood actress and producer Mary Remmy Njoku has issued a stark warning about the quality of medications circulating in Nigeria after experiencing what she describes as a stark difference between locally purchased and foreign-acquired drugs.
The incident, which occurred following a bout of food poisoning on a film set, has prompted the actress to call for immediate regulatory intervention.
In a detailed Instagram post shared on Tuesday, Njoku recounted her troubling experience with Imodium, a widely used anti-diarrheal medication. After developing food poisoning while working on set, she dispatched a staff member to purchase the medicines from what she described as “a well-known pharmacy chain in Nigeria”—a medication she had successfully used on previous occasions.
However, the actress reported that despite taking the locally purchased Imodium for three consecutive days, her symptoms persisted with no improvement. The situation took a dramatic turn when her husband provided her with the same medication purchased abroad. According to Njoku, relief came within minutes of taking the foreign-acquired tablet.
“This isn’t the first time I have noticed a difference,” Njoku emphasized in her post, suggesting a pattern of substandard medications in Nigeria’s pharmaceutical market. Her pointed question—”What exactly are we being sold in Nigeria?”—has resonated across social media platforms, drawing attention to a crisis that health experts have long warned about.
The actress’s experience comes against the backdrop of a well-documented counterfeit drug epidemic in Nigeria. According to Nigerian drug regulators, more than 70% of the drugs consumed in Nigeria are imports, and NAFDAC admitted last February that about half of them are fake. This alarming statistic underscores the magnitude of the challenge facing Africa’s most populous nation.
Njoku has specifically appealed to the National Agency for Food and Drug Administration and Control (NAFDAC) to investigate the matter, describing it as “a public health risk” that must be taken seriously. Her call for action highlights the critical role of regulatory agencies in ensuring the safety and efficacy of medications reaching Nigerian consumers.
The actress’s public disclosure represents more than an isolated incident—it reflects the experiences of countless Nigerians who may have unknowingly consumed substandard or counterfeit medications. Her platform as a public figure has amplified concerns that healthcare professionals and regulatory bodies have been grappling with for years.
The timing of Njoku’s revelation is particularly significant, as NAFDAC has recently introduced new tools to fight fake drugs in Nigeria, including an online database (Green Book), a traceability regulation, and a new pediatric regulation. However, the actress’s experience suggests that despite these initiatives, counterfeit medications continue to infiltrate the supply chain through established pharmaceutical retailers.
This incident raises critical questions about the effectiveness of current screening mechanisms and quality control measures within Nigeria’s pharmaceutical distribution network. The fact that the medication was purchased from a “prominent pharmacy chain” rather than an informal vendor underscores the depth of the problem and the sophisticated nature of counterfeit drug operations.
For the Nigerian public, Njoku’s testimony serves as both a warning and a call to action. Her willingness to share this experience publicly demonstrates the urgent need for citizens to remain vigilant about the medications they consume and to support regulatory efforts to combat the counterfeit drug trade.
As investigations into this specific case potentially unfold, the broader implications for Nigeria’s healthcare system remain clear: the battle against counterfeit drugs requires sustained commitment from regulatory agencies, pharmaceutical companies, and the public to ensure that life-saving medications remain both safe and effective for all Nigerians.
WHAT YOU SHOULD KNOW
Nollywood actress Mary Remmy Njoku’s recent experience exposes a dangerous reality: even medications purchased from reputable pharmacy chains in Nigeria may be counterfeit or substandard. After locally bought Imodium failed to work for three days, the same medication purchased abroad provided relief within minutes.
Over 70% of drugs in Nigeria are imports, with NAFDAC admitting about half are fake.
Counterfeit drugs are infiltrating established pharmacy chains, not just informal vendors
This represents a serious public health risk that affects all Nigerians
NAFDAC has been called upon to investigate and strengthen oversight
